Your browser doesn't support javascript.
loading
Constructing a developmental and reproductive toxicity database of chemicals (DART NIHS DB) for integrated approaches to testing and assessment.
Yamada, Takashi; Miura, Minoru; Kawamura, Tomoko; Ushida, Kazuo; Inoue, Kaoru; Kuwagata, Makiko; Katsutani, Naruo; Hirose, Akihiko.
Afiliação
  • Yamada T; Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences (NIHS).
  • Miura M; Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences (NIHS).
  • Kawamura T; Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences (NIHS).
  • Ushida K; Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences (NIHS).
  • Inoue K; Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences (NIHS).
  • Kuwagata M; Division of Cellular and Molecular Toxicology, Center for Biological Safety Research, National Institute of Health Sciences (NIHS).
  • Katsutani N; Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences (NIHS).
  • Hirose A; Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences (NIHS).
J Toxicol Sci ; 46(11): 531-538, 2021.
Article em En | MEDLINE | ID: mdl-34719556
Developmental and reproductive toxicity (DART) is an important endpoint, and databases (DBs) are essential for evaluating the risk of untested substances using alternative methods. We have constructed a reliable and transparent DART DB, which we named DART NIHS DB, using the publicly available datasets of DART studies of industrial chemicals conducted by Japanese government ministries in accordance with the corresponding OECD test guidelines (OECD TG421 and TG422). This DB is unique because its dataset chemicals have little overlap with those of ToxRefDB, which compiles large-scale DART data, and it is reliable because the included datasets were created after reviewing the individual study reports. In DART NIHS DB, 171 of 404 substances exhibited signs of DART, which occurred during fertility and early embryonic development (49 substances), organogenesis (59 substances), and the perinatal period (161 substances). When the lowest-observed-adverse-effect level (LOAEL) of DART was compared with that of repeated-dose toxicity (RDT), 15 substances (12%) had a lower LOAEL for DART than for RDT. Of these, five substances displayed significant DART at doses of ≤ 50 mg/kg bw/day. The chemical and toxicity information in this DB will be useful for the development of stage-specific adverse outcome pathways (AOPs) via integration with mechanistic information. The whole datasets of the DB can be implemented in read-across support tools such as the OECD QSAR Toolbox, which will further lead to future integrated approaches to testing and assessment based on AOPs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes de Toxicidade / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Toxicol Sci Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes de Toxicidade / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Toxicol Sci Ano de publicação: 2021 Tipo de documento: Article